Bone and fat mass in relation to postnatal levels of insulin-like growth factors in prematurely born children at 4 y of age.
BACKGROUND
Children born prematurely may be at risk of developing osteopenia. This study investigated whether insulin-like growth factors (IGFs) in the early postnatal period influence bone mass and body composition in prematurely born children.


METHODS
A total of 74 control (gestational age >36 wk; n = 37) and preterm (gestational age <32 wk; n = 37) infants were investigated (mean age ± SD: 4.59 ± 0.31 y). Bone mineral density, body composition, and markers of bone and mineral metabolism were investigated in relation to postnatal IGF levels.


RESULTS
After adjusting for confounders, we found no differences in bone mass, but significantly less lean mass, increased fat mass, and increased osteocalcin levels in ex-preterm infants. Forward stepwise multiple analysis revealed that higher late postnatal IGF-II levels predict lumbar spine bone mineral content (P < 0.05) and lean mass (P < 0.05). When the birth weight standard deviation score was included in the analysis, higher early postnatal IGF-I levels predicted both lumbar spine bone mineral density and bone mineral content (P < 0.05). Higher early postnatal IGF binding protein-3 (P < 0.01) predicted increased fat mass at 4-y follow-up.


CONCLUSIONS
Ex-preterm children have normal bone mass but different body composition compared with full-term controls. Higher early IGF-I and late postnatal IGF-II concentrations are positive predictors of lumbar spine bone mass.
Department of Pediatrics, Institute for Clinical Sciences, The Queen Silvia Children's Hospital, The Sahlgrenska Academy, Göteborg University, Göteborg, Sweden.
Lennart
L
Stigson
The Sahlgrenska Center for Pediatric Ophthalmology Research, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, Göteborg University, Göteborg, Sweden.
Anna
A
Kistner
Department of Pediatrics, Institute for Clinical Sciences, The Queen Silvia Children's Hospital, The Sahlgrenska Academy, Göteborg University, Göteborg, Sweden.
Jon
J
Sigurdsson
Department of Pediatrics, Institute for Clinical Sciences, The Queen Silvia Children's Hospital, The Sahlgrenska Academy, Göteborg University, Göteborg, Sweden.
Eva
E
Engström
Division of Clinical Chemistry, Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, Linköping, Sweden.
Per
P
Magnusson
The Sahlgrenska Center for Pediatric Ophthalmology Research, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, Göteborg University, Göteborg, Sweden.
Ann
A
Hellström
Department of Pediatrics, Institute for Clinical Sciences, The Queen Silvia Children's Hospital, The Sahlgrenska Academy, Göteborg University, Göteborg, Sweden.
Diana
D
Swolin-Eide
D000273:Adipose Tissue; D001842:Bone and Bones; D016022:Case-Control Studies; D002675:Child, Preschool; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D009929:Organ Size; D013002:Somatomedins / Q000378:metabolism*
D013002:Somatomedins